PillRx only · Injection, Solution · Subcutaneous
Insulin Degludec And Liraglutide
Brands: Xultophy 100/3.6 · Insulin Degludec + Liraglutide
1 ACTIVE SUPPLIER — US
openFDA · updated weekly
US1 NDCs
1 active makers
1 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 1 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$85.904
Latest avg · Jul 22, 2026
+0%
Since Dec 17, 2025
1
Active US suppliers
100%
Top-2 supplier share*